CENTRAL NERVOUS SYSTEM FUNGAL INFECTION

CENTRAL NERVOUS SYSTEM FUNGAL INFECTION was reported 232 times

CENTRAL NERVOUS SYSTEM FUNGAL INFECTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antileishmanial [EPC] 2 0.0052
1 Lipid-based Polyene Antifungal [EPC] 34 0.0026
2 Nucleoside Analog Antifungal [EPC] 3 0.0021
3 Echinocandin Antifungal [EPC] 10 0.0012
4 Selective T Cell Costimulation Blocker [EPC] 5 0.0011
5 Polyene Antifungal [EPC] 36 0.0009
6 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 16 0.0007
7 Hematopoietic Stem Cell Mobilizer [EPC] 1 0.0007
8 Antimetabolite Immunosuppressant [EPC] 13 0.0006
9 Topoisomerase Inhibitor [EPC] 38 0.0005
10 Azole Antifungal [EPC] 61 0.0004
11 Antimalarial [EPC] 4 0.0004
12 Antiprotozoal [EPC] 4 0.0004
13 Penem Antibacterial [EPC] 10 0.0003
14 CD52-directed Cytolytic Antibody [EPC] 5 0.0003
15 Antiparasitic [EPC] 1 0.0002
16 Pediculicide [EPC] 1 0.0002
17 Alkylating Drug [EPC] 41 0.0002
18 Oxazolidinone Antibacterial [EPC] 5 0.0002
19 Aminoglycoside Antibacterial [EPC] 7 0.0002
20 Nucleoside Metabolic Inhibitor [EPC] 42 0.0002
21 Asparagine-specific Enzyme [EPC] 2 0.0001
22 Allylamine Antifungal [EPC] 1 0.0001
23 Calcineurin Inhibitor Immunosuppressant [EPC] 17 0.0001
24 Tetracycline-class Antibacterial [EPC] 1 0.0001
25 Antimycobacterial [EPC] 3 0.0001
26 Glycopeptide Antibacterial [EPC] 7 0.0001
27 Lipopeptide Antibacterial [EPC] 1 0.0001
28 Purine Antimetabolite [EPC] 10 0.0001
29 CD20-directed Cytolytic Antibody [EPC] 31 0.0001
30 Corticosteroid [EPC] 121 0.0001
31 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 1 0.0001
32 Fluoroquinolone Antibacterial [EPC] 9 0.0001
33 Kinase Inhibitor [EPC] 37 0.0001
34 Central alpha-2 Adrenergic Agonist [EPC] 3 0.0001
35 Rifamycin Antibacterial [EPC] 2 0.0001
36 BCL-2 Inhibitor [EPC] 3 0.0000
37 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
38 Folate Analog Metabolic Inhibitor [EPC] 16 0.0000
39 Complement Inhibitor [EPC] 2 0.0000
40 Integrin Receptor Antagonist [EPC] 3 0.0000
41 Serotonin Reuptake Inhibitor [EPC] 3 0.0000
42 Janus Kinase Inhibitor [EPC] 5 0.0000
43 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0000
44 Factor Xa Inhibitor [EPC] 7 0.0000
45 P2Y12 Platelet Inhibitor [EPC] 3 0.0000
46 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2 0.0000
47 Tetracycline-class Drug [EPC] 1 0.0000
48 Aldosterone Antagonist [EPC] 2 0.0000
49 Anti-IgE [EPC] 1 0.0000
50 Platelet Aggregation Inhibitor [EPC] 5 0.0000
51 Proteasome Inhibitor [EPC] 1 0.0000
52 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
53 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
54 Proton Pump Inhibitor [EPC] 4 0.0000
55 Vitamin D [EPC] 2 0.0000
56 Vitamin B12 [EPC] 2 0.0000
57 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
58 Tumor Necrosis Factor Blocker [EPC] 6 0.0000
59 Thalidomide Analog [EPC] 3 0.0000
60 Vitamin C [EPC] 2 0.0000
61 Nonsteroidal Anti-inflammatory Drug [EPC] 6 0.0000
62 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
63 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
64 Benzodiazepine [EPC] 1 0.0000